Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Nurexone Biologic Inc (NRXBF)

Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch Watch
Help
Go To:
NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results GlobeNewswire - 1 hour ago

TORONTO and HAIFA, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc.  (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biotechnology company developing...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results GlobeNewswire - 1 hour ago

TORONTO and HAIFA, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”),...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference GlobeNewswire - Fri Aug 28, 3:01PM CDT

TORONTO and HAIFA, Israel, Aug. 28, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biotechnology company developing...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference GlobeNewswire - Fri Aug 28, 3:01PM CDT

TORONTO and HAIFA, Israel, Aug. 28, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”),...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy GlobeNewswire - Fri Aug 21, 3:03PM CDT

Proposed share consolidation of up to 30:1 intended to support potential U.S. exchange listing and broaden investor appeal TORONTO and HAIFA, Israel, Aug. 21, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy GlobeNewswire - Fri Aug 21, 3:03PM CDT

Proposed share consolidation of up to 30:1 intended to support potential U.S. exchange listing and broaden investor appeal

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Announces Closing of C$1,066,078 Private Placement GlobeNewswire - Thu Aug 20, 4:01PM CDT

TORONTO, and HAIFA, Israel, Aug. 21, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biopharmaceutical company developing...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Announces Closing of C$1,066,078 Private Placement GlobeNewswire - Thu Aug 20, 4:01PM CDT

TORONTO, and HAIFA, Israel, Aug. 21, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”),...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Reports New Preclinical Tissue-Analysis Data Supporting Potential Neuroprotective Effect of ExoPTEN in Acute Spinal Cord Injury Animal Model GlobeNewswire - Fri Aug 14, 7:59AM CDT

TORONTO and HAIFA, Israel, Aug. 14, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (" NurExone " or the " Company ") (TSXV: NRX, OTCQB: NRXBF, FSE: J90), a biotechnology company developing exosome-based...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Reports New Preclinical Tissue-Analysis Data Supporting Potential Neuroprotective Effect of ExoPTEN in Acute Spinal Cord Injury Animal Model GlobeNewswire - Fri Aug 14, 7:59AM CDT

Tissue analysis showed significantly higher numbers of myelin-positive cells in ExoPTEN-treated animals compared with controls, providing additional preclinical biological support for previously reported...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)

Barchart Exclusives

Netflix Puts Worth Shorting Here for High One-Month Yields Barchart - 7 minutes ago
Netflix stock has risen after dipping post-earnings. Moreover, even if NFLX takes a breather or trades in a range, it may be worth shorting out-of-the-money puts to set a lower buy-in price. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.